financetom
Business
financetom
/
Business
/
Research Alert: CFRA Keeps Hold View On Shares Of The Estee Lauder Companies Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold View On Shares Of The Estee Lauder Companies Inc.
Mar 24, 2026 10:32 AM

01:10 PM EDT, 03/24/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

EL shares are down ~9% in intra-day trading resulting from reports that EL is in discussions to merge with Spain's Puig. We think the potential merger could help EL gain exposure to both the fragrance industry and a younger consumer as EL is traditionally known for skin care/makeup products that target a more mature consumer. Although we do not think that the combined company could out-compete LVMH or L'Oreal, we see it positioning EL favorably vs. COTY as Puig owns its brands vs. COTY's business model of licensing products. We also think the combined EL-Puig company would have more leverage when it comes to negotiations with retailers. With no final decision made and no agreement reached, we believe the market reaction reflects concerns of dilution and cash use amid an already strenuous turnaround strategy in EL's business. We see the merger adding integration risk and complexity to operations, and stressing the balance sheet fairly soon after gaining its footing with the Tom Ford acquisition.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cybin to Transfer Listing to Nasdaq From NYSE American
Cybin to Transfer Listing to Nasdaq From NYSE American
Mar 10, 2026
08:39 AM EST, 12/18/2025 (MT Newswires) -- Cybin ( CYBN ) said Thursday that it will voluntarily transfer its listing to the Nasdaq Global Market from the NYSE American. Cybin ( CYBN ) said it expects its common shares will cease trading at the NYSE American at market close on Jan. 4 and start trading on Nasdaq at market open...
ATS Receives Approval From TSX for Normal Course Issuer Bid
ATS Receives Approval From TSX for Normal Course Issuer Bid
Mar 10, 2026
08:39 AM EST, 12/18/2025 (MT Newswires) -- ATS (TSX and NYSE: ATS) on Thursday said that the Toronto Stock Exchange approved the company's notice of intention to make a normal course issuer bid (NCIB). Under the bid, the company will have the ability to buy back for cancellation up to a maximum of 8.2-million common shares, about 10% of the...
Alight Appoints Greg Giometti as Interim Chief Financial Officer
Alight Appoints Greg Giometti as Interim Chief Financial Officer
Mar 10, 2026
08:38 AM EST, 12/18/2025 (MT Newswires) -- Alight (ALIT) said Thursday it has appointed Greg Giometti as the company's interim chief financial officer, effective Jan. 9, 2026. Giometti succeeds Jeremy Heaton, who will depart Alight to pursue another opportunity, the company said. Giometti joined Alight in 2020 and currently serves as the company's senior vice president, head of financial planning...
CAMP4 Therapeutics, GSK Collaborate to Develop RNA-Based Therapeutics for Neurodegenerative and Kidney Diseases
CAMP4 Therapeutics, GSK Collaborate to Develop RNA-Based Therapeutics for Neurodegenerative and Kidney Diseases
Mar 10, 2026
08:38 AM EST, 12/18/2025 (MT Newswires) -- CAMP4 Therapeutics ( CAMP ) said Thursday it has entered a research, collaboration and license agreement with GSK (GSK) to identify and develop antisense oligonucleotide drug candidates targeting neurodegenerative and kidney disease indications. Under the agreement, CAMP4 Therapeutics ( CAMP ) will receive upfront cash payment of $17.5 million and is eligible for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved